https://adisinsight.springer.com/trials/700290146?error=cookies_not_supported&code=fb84b3b2-de1b-41e8-b5a9-4c24006c74f5
A phase I/IIa clinical trial of rAAVrh74.MCK.GALGT2 gene therapy in patients with Duchenne muscular...
This study will evaluate rAAVrh74.MCK.GALGT2 gene therapy in patients with Duchenne muscular dystrophy (DMD).